Synthesis and biological evaluation of 2,5-dihydropyrazol

M I Crespo1, J Gràcia, C Puig

  • 1Almirall Prodesfarma, Research Centre, Barcelona, Spain. macrespo@almirallprodesfarma.com

Summary

Researchers developed new pyrazoloquinolinones with potent phosphodiesterase 4 (PDE4) inhibition. These compounds show anti-inflammatory effects without causing nausea, offering a promising therapeutic avenue.